Gapro Medica - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 31,293 | 59,574 | 68,603 | 126,645 | 102,287 | 122,316 | 105,715 | 140,031 |
| Profit before tax | 4,559 | 17,468 | 16,613 | 20,402 | 36,165 | 41,674 | 9,271 | 50,387 |
| Net profit | 4,311 | 16,561 | 15,770 | 19,278 | 34,341 | 39,560 | 8,765 | 47,348 |
| Equity | 27,457 | 44,020 | 59,789 | 79,067 | 113,408 | 140,969 | 137,969 | 169,317 |
| Liabilities | 1,802 | 7,836 | 9,060 | 15,432 | 12,957 | 11,362 | 24,900 | 13,992 |
| Non-current assets | 5,312 | 5,132 | 4,525 | 3,986 | 3,579 | 17,125 | 15,287 | 13,478 |
| Current assets | 23,947 | 46,724 | 64,324 | 90,513 | 122,689 | 134,894 | 147,245 | 169,487 |
| Total assets | 29,259 | 51,856 | 68,849 | 94,499 | 126,268 | 152,019 | 162,532 | 182,965 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 17,622 | 19,720 | 24,322 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +29.2% | +90.4% | +15.2% | +84.6% | -19.2% | +19.6% | -13.6% | +32.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.7% | 31.9% | 22.9% | 20.4% | 27.2% | 26.0% | 5.4% | 25.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 15.7% | 37.6% | 26.4% | 24.4% | 30.3% | 28.1% | 6.4% | 28.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.8% | 27.8% | 23.0% | 15.2% | 33.6% | 32.3% | 8.3% | 33.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 14.6% | 29.3% | 24.2% | 16.1% | 35.4% | 34.1% | 8.8% | 36.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 31,293 | 59,574 | 68,603 | 126,645 | 102,287 | 122,316 | 105,715 | 140,031 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gapro Medica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-28 | 2023-08-15 | 0.24 |
| 2023-07-24 | 2023-07-25 | 0.24 |
| 2023-07-18 | 2023-07-18 | 203.86 |
| 2023-04-18 | 2023-04-19 | 202.79 |
| 2022-04-19 | 2022-04-19 | 175.68 |
| 2022-03-16 | 2022-03-16 | 176.68 |
| 2022-01-31 | 2022-02-13 | 0.51 |
| 2021-12-16 | 2021-12-19 | 155.82 |
| 2021-11-16 | 2021-11-17 | 156.15 |
| 2021-11-05 | 2021-11-15 | 0.33 |
Gapro Medica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-19 | 2026-08-20 | 1.3 |
| 2026-07-30 | 2026-08-18 | 0.9 |
| 2026-06-28 | 2026-07-07 | 0.54 |
| 2026-05-25 | 2026-05-25 | 0.1 |
| 2026-03-21 | 2026-03-22 | 0.58 |
| 2025-09-23 | 2025-09-23 | 3.21 |
| 2025-06-30 | 2025-07-20 | 0.35 |
| 2025-05-29 | 2025-06-12 | 0.17 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gapro Medica, UAB (company code 302366259) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue increased to €140.0K, up 32.5% year on year and 14.5% compared with 2023. Net profit reached €47.3K, following €8.8K in 2024 and €39.6K in 2023, indicating a temporary decline in 2024 and a strong recovery in 2025. The profit margin improved to 33.8% in 2025 from 8.3% in 2024. Total assets rose to €183.0K in 2025 from €162.5K a year earlier, while equity increased to €169.3K and liabilities remained low at €14.0K. The equity ratio stood at 92.5%, and debt-to-equity was 0.08. Return on equity was 28.0% and return on assets 25.9%, supported by asset turnover of 0.77x. Revenue per employee was €140.0K and profit per employee €47.3K.